Novartis has teamed up with biopharmaceutical investor Blackstone Life Sciences to launch a new biotech start up, Anthos Therapeutics.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.